Literature DB >> 30930185

Diagnosis and surgical management of pericardial effusion due to paragonimiasis.

Yuhao Wu1, Yuehang Zhou1, Xin Jin1, Yonggang Li1, Hongbo Li1, Jiangtao Dai1, Gang Wang1, Chun Wu2.   

Abstract

OBJECTIVES: The pericardial effusion (PE) caused by paragonimiasis is rarely reported. This study aims to present experience in the diagnosis and surgical management of PE due to paragonimiasis.
METHODS: Medical records of 57 children who were diagnosed with PE due to paragonimiasis and underwent surgery at Children's Hospital of Chongqing Medical University between January 2012 and August 2018 were retrospectively reviewed.
RESULTS: The average age of this group was 7.6 ± 3.0 years. Patients were mainly from Chongqing and Sichuan areas. ELISA for Paragonimus skrjabini in all 57 patients showed positive results. Moderate or large PE were identified in 12 and 45 patients, respectively. All patients underwent surgery either by pericardectomy or thoracoscopic surgery. Pathological exams indicated massive eosinophil infiltration in all 57 specimens. After 3-4 courses of praziquantel therapy, the clinical outcomes were satisfactory.
CONCLUSIONS: Typical endemic history, eosinophilia and multiple serous effusion raise suspicions of paragonimiasis. Once moderate to large PE is identified in patients with paragonimiasis, surgical treatment is necessary.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Children; Diagnosis; Paragonimiasis; Pericardial effusion; Surgery

Mesh:

Substances:

Year:  2019        PMID: 30930185     DOI: 10.1016/j.ijid.2019.03.032

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  1 in total

1.  Paragonimus infection: Rare manifestation with pericardial effusion: A Case report and Literature review.

Authors:  Ahmad Al Bishawi; Sarah Salameh; Ahsan Ehtesham; Ihab Massad; Suresh Arachchige; Ahmed Hatim; Issam Bozom; Maliha Thapur
Journal:  IDCases       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.